Green Cross Cell Explores Biotech Opportunities in Russia
Posted on 09/13/2018
The Russian Direct Investment Fund (RDIF), Sistema PJSFC, a publicly traded diversified Russian holding company, and Sistema portfolio company Medsi have inked a deal with Green Cross Cell Corporation to develop the field of biotechnology in the Russian Federation. Seoul-based Green Cross Cell produces the drug Immuncell-LC, which aims to reduce the risk of metastasis […]
